Manufacturing and preclinical studies are currently in progress to enable clinical testing of the first coxsackievirus B vaccine for type 1 diabetes.
Manufacturing of a clinical CVB vaccine as well as preclinical studies are currently in progress in order to enable clinical testing of the first CVB vaccine. Ongoing scientific research projects can significantly facilitate this effort by providing insights into the mechanisms of the CVB-T1D association.
Hyöty et al. (Tue,) studied this question.